Get FREE SHIPPING when you spend $99 or more | ATOMFAIR

Awaiting product image

Atomfair Piroxicam-beta-cyclodextrincomplex C57H83N3O39S CAS 96684-39-8

The Piroxicam-beta-cyclodextrincomplex (CAS No. 96684-39-8) is a pharmaceutical-grade inclusion complex formed between piroxicam, a potent nonsteroidal anti-inflammatory drug (NSAID), and beta-cyclodextrin, a cyclic oligosaccharide known for enhancing solubility and bioavailability. This complex is characterized by the molecular formula C57H83N3O39S , ensuring high purity and stability for research and formulation applications. The inclusion of piroxicam within the beta-cyclodextrin cavity improves its dissolution rate, making it ideal for oral and topical formulations targeting inflammation and pain management. This product is rigorously tested for compliance with pharmacopeial standards, ensuring reproducibility and reliability for scientific and industrial use.

Category:

Description

The Piroxicam-beta-cyclodextrincomplex (CAS No. 96684-39-8) is a pharmaceutical-grade inclusion complex formed between piroxicam, a potent nonsteroidal anti-inflammatory drug (NSAID), and beta-cyclodextrin, a cyclic oligosaccharide known for enhancing solubility and bioavailability. This complex is characterized by the molecular formula C57H83N3O39S, ensuring high purity and stability for research and formulation applications. The inclusion of piroxicam within the beta-cyclodextrin cavity improves its dissolution rate, making it ideal for oral and topical formulations targeting inflammation and pain management. This product is rigorously tested for compliance with pharmacopeial standards, ensuring reproducibility and reliability for scientific and industrial use.

Properties

  • CAS Number: 96684-39-8
  • Complexity: 2090
  • IUPAC Name: 5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol;4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1lambda6,2-benzothiazine-3-carboxamide
  • InChI: InChI=1S/C42H70O35.C15H13N3O4S/c43-1-8-29-15(50)22(57)36(64-8)72-30-9(2-44)66-38(24(59)17(30)52)74-32-11(4-46)68-40(26(61)19(32)54)76-34-13(6-48)70-42(28(63)21(34)56)77-35-14(7-49)69-41(27(62)20(35)55)75-33-12(5-47)67-39(25(60)18(33)53)73-31-10(3-45)65-37(71-29)23(58)16(31)51;1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h8-63H,1-7H2;2-9,19H,1H3,(H,16,17,20)
  • InChI Key: LBPBSKKEZXLVBQ-UHFFFAOYSA-N
  • Exact Mass: 1465.4324410
  • Molecular Formula: C57H83N3O39S
  • Molecular Weight: 1466.3
  • SMILES: CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3.C(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)CO)CO)CO)CO)CO)CO)O)O)O
  • Topological: 662
  • Monoisotopic Mass: 1465.4324410
  • Synonyms: Piroxicam-beta-cyclodextrincomplex, 96684-39-8, b-Cyclodextrin, compd. with4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide (1:1)OTHER CA INDEX NAMES:2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide, compd. withb-cyclodextrin (1:1), Piroxicam-|A-cyclodextrincomplex, BCP10841, AS-84271, 4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1??,2-benzothiazine-3-carboxamide; 5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2(3),?.2?,(1)(1).2(1)(3),(1)?.2(1)?,(2)(1).2(2)(3),(2)?.2(2)?,(3)(1)]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol, 5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol;4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide

The Piroxicam-beta-cyclodextrincomplex is primarily used in pharmaceutical research to develop enhanced drug delivery systems, particularly for improving the solubility and bioavailability of piroxicam. It is also employed in preclinical studies for anti-inflammatory and analgesic formulations. This complex is suitable for exploring novel oral or topical delivery mechanisms in therapeutic applications.

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.

Disclaimer

Intended Use & Restrictions

This product is sold exclusively for laboratory research, analytical testing, or non-commercial purposes.

  • Strictly prohibited: Resale, repackaging, or formulation into commercial products.
  • Not approved for human/animal use, diagnostics, or manufacturing (including pharmaceuticals, agrochemicals, or consumer goods).

Patent & Regulatory Compliance

Certain molecules may be protected by active patents or regulatory restrictions.

  • Buyers must independently verify patent status (e.g., via USPTO/EPO/CNIPA) and comply with local laws.
  • Atomfair LLC does not provide legal assurances regarding patent non-infringement or jurisdictional compliance.

Liability Release

By purchasing, the buyer agrees to:

  • Use this product only as permitted by law.
  • Indemnify Atomfair LLC against all claims arising from misuse, patent infringement, or regulatory violations.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products